Effects of Vaginal vs. Oral Progesterone Supplementation Before Embryo Transfer on Live Birth Rates and Levels: A Randomized Trial
in Reproduction and FertilitySearch for other papers by Gorka Barrenetxea in
Current site
Google Scholar
PubMed
Search for other papers by Olaia Prego in
Current site
Google Scholar
PubMed
Search for other papers by Ricardo Celis in
Current site
Google Scholar
PubMed
Search for other papers by Edurne Martínez in
Current site
Google Scholar
PubMed
Search for other papers by María De Las Heras in
Current site
Google Scholar
PubMed
Search for other papers by Oihane Gómez in
Current site
Google Scholar
PubMed
Search for other papers by Olaia Aguirre in
Current site
Google Scholar
PubMed
Search for other papers by Sheila Samojluk in
Current site
Google Scholar
PubMed
Search for other papers by Julen Barrenetxea in
Current site
Google Scholar
PubMed
The increase in frozen embryo transfers is a consequence of advances in embryo vitrification and the implementation of genetic screening of embryos. There is debate over the best progesterone administration route in substituted cycles and the relationship between progesterone levels on embryo transfer day and reproductive outcomes.
This trial aimed to compare the clinical results of different progesterone supplementation schedules before embryo transfer and assess the relationship between plasmatic progesterone levels on transfer day and clinical outcomes.
In a prospective, randomized, controlled study, 500 patients were randomly divided into two groups based on the progesterone administration route (oral or vaginal) prior to embryo transfer. Progesterone levels were measured on embryo transfer day (PP1) and B-HCG determination (PP2). The primary endpoint was the live birth rate according to different progesterone schedules and progesterone levels on transfer day.
Despite higher plasmatic progesterone levels with oral administration compared to the vaginal route, there were no significant differences in clinical pregnancy (50.20% vs. 47.37%), live birth (43.67% vs. 40.89%), or miscarriage rates (13.33% vs. 6.48%).
Progesterone levels on transfer day were significantly higher in patients with ongoing pregnancies (24.96±1.00 ng/ml) compared to those without (18.02±1.07 ng/ml) (p=0.001). Among patients with positive pregnancy tests, the differences between progressing and non-progressing pregnancies were not statistically significant.
In brief
Although different routes of progesterone administration resulted in varying plasma levels on the day of embryo transfer (ET), these differences did not affect reproductive outcomes.
Reproduction and Fertility is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
As an open-access journal, Reproduction and Fertility articles are immediately available to read on publication, without restriction. The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
| Sept 2018 onwards | Past Year | Past 30 Days | |
|---|---|---|---|
| Full Text Views | 150 | 150 | 149 |
| PDF Downloads | 135 | 135 | 135 |
Online ISSN: 2633-8386
Strengthening biomedical communities
to advance science and health
CONTACT US
Bioscientifica Ltd | Starling House | 1600 Bristol Parkway North | Bristol BS34 8YU | UK
Bioscientifica Ltd | Registered in England no 3190519